Abstract:Chronic obstructive pulmonary disease (COPD) is characterized by aberrant inflammatory and repair responses, leading to bronchitis, small airway remodeling, and emphysema. It is the third leading cause of death worldwide and is caused by exposure to tobacco smoke or environmental pollutants (1). Importantly, the inflammatory processes in COPD are known to persist long after smoking cessation (2). However, the underlying mechanisms that initiate and drive inflammation are still not clear, and currently, no pharmacological treatments are available to alter the course of the disease. These mechanisms include defective epithelial repair in the airways and alveoli, suggesting that the endogenous lung stem cells may be the initial drivers of the disease. In line with that, research has demonstrated that basal (stem) cells in the airway are among the first cells to be affected by inhaled toxins, resulting in epithelial damage, defective repair, and subsequent inflammation (3, 4). The mechanisms triggering the initiation of this inflammation are not understood, but it is clear that the epithelial cells are in constant communication with the inflammatory cells. It was recently shown that a subpopulation of basal cells can drive the inflammatory processes observed in COPD, suggesting that these inflammatory signals represent a potential therapeutic target to inhibit tissue destruction and promote regeneration of the normal cells that still exist in the airways at end-stage COPD (5, 6). In the alveolar compartment, the alveolar type 2 (AT2) cells are the stem cells responsible for homeostasis and regeneration ( Figure 1A ). Even though AT2 cells have been evaluated in multiple single-cell OMICS studies (7–9), the mechanistic alterations in AT2 cells in COPD are unknown, and the question remains as to whether a disease-propagating subpopulation of AT2 cells exists in COPD. Hence, a deeper understanding of the AT2 cells in patients with COPD is needed to understand their contribution to disease.

Cell cycle kinetics in the alveolar epithelium

Regulation of Alveolar Type 2 Stem/progenitor Cells in Lung Injury and Regeneration

Alveolar Type Ii Cells Possess The Capability Of Initiating Lung Tumor Development

Alveolar epithelial transport in the adult lung

Aging-Associated Molecular Changes in Human Alveolar Type I Cells

Epithelial stem cells and niches in lung alveolar regeneration and diseases

The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung

Inflammatory Alveolar Type 2 Cells in Chronic Obstructive Pulmonary Disease: Impairing or Improving Disease Outcome?

Characterization of Commercially Available Human Primary Alveolar Epithelial Cells

Alveolar wars: The rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease

Enhanced glycolysis-mediated energy production in alveolar stem cells is required for alveolar regeneration

Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro.

Trans-differentiation of Alveolar Epithelial Type II Cells to Type I Cells Involves Autocrine Signaling by Transforming Growth Factor Β1 Through the Smad Pathway

Repair and regeneration of the alveolar epithelium in lung injury

Alveolar epithelial progenitor cells require Nkx2-1 to maintain progenitor-specific epigenomic state during lung homeostasis and regeneration

Acquisition of cellular properties during alveolar formation requires differential activity and distribution of mitochondria

Transcriptomics Analysis Identifies the Decline in the Alveolar Type II Stem Cell Niche in Aged Human Lungs

Contributions of alveolar epithelial cell quality control to pulmonary fibrosis

Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis

Multi-apical polarity of alveolar stem cells and their dynamics during lung development and regeneration

Alveolar Type I Cells Protect Rat Lung Epithelium From Oxidative Injury